Iraq vs Kuwait: Tuberculosis patients living with HIV receiving antiretroviral therapy
Iraq
2 patients
in 2021
Kuwait
2 patients
in 2021
Iraq rank
125th
Kuwait rank
125th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Iraq
- Kuwait
How they compare
Iraq currently reports 2 patients against 2 patients in Kuwait, a difference of 0 patients.
The two have swapped places 4 times across 16 shared years of data; in 2006 it was Kuwait ahead.
Iraq ranks 125th and Kuwait ranks 125th of 183 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 2.5 patients | 2.5 patients | Kuwait |
| 2010s | 0.6 patients | 1.8 patients | 1.2 patients | Kuwait |
| 2020s | 1.5 patients | 3 patients | 1.5 patients | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Iraq or Kuwait?
- Iraq, at 2 patients against 2 patients in Kuwait as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Iraq and Kuwait?
- 0 patients, with Iraq ahead.
- How many years of comparable data are there for Iraq and Kuwait?
- 16 years are reported by both, from 2006 to 2021.
- How do Iraq and Kuwait rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Iraq ranks 125th and Kuwait ranks 125th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.